RECOMMENDATION ON THE TREATMENT OF DYSLIPIDEMIA (ESC/EAS) 2016: FOCUS ON APPLICATION OF NON-STATIN LIPID-LOWERING THERAPY


Ya.I. Ashikhmin (1), D.Yu. Schekochikhin (2)

(1) Yusupov Hospital, Moscow (2) FSBEI HE “First MSMU n.a. I.M. Sechenov” of RMH, Moscow
The article highlights the key aspects of the recommendations on treatment of dyslipidemia (ESC/EAS) 2016. In particular, the strategy of the initiation of lipid-lowering therapy, and the recommended target low density lipoprotein levels in different clinical groups are discussed. A special attention is given to the application of new non-statin drugs for the correction of dyslipidemia: ezetimibe and PCSK9 inhibitors.

About the Autors


Corresponding author: Ya.I.Ashikhmin – PhD, Cardiologist, Deputy General Director for Medicine of the Yusupov Hospital, Moscow; tel. 8 (499) 750-00-04; e-mail: ya.ashikhmin@gmail.com


Similar Articles


Бионика Медиа